267 related articles for article (PubMed ID: 9384707)
1. Long-term interleukin-3 and intensive immunosuppression in the treatment of aplastic anemia.
Raghavachar A; Ganser A; Freund M; Heimpel H; Herrmann F; Schrezenmeier H
Cytokines Mol Ther; 1996 Dec; 2(4):215-23. PubMed ID: 9384707
[TBL] [Abstract][Full Text] [Related]
2. A phase I/II study of interleukin-3 in patients with aplastic anemia and myelodysplasia.
Nimer SD; Paquette RL; Ireland P; Resta D; Young D; Golde DW
Exp Hematol; 1994 Aug; 22(9):875-80. PubMed ID: 8062886
[TBL] [Abstract][Full Text] [Related]
3. Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. The German Aplastic Anemia Study Group.
Frickhofen N; Kaltwasser JP; Schrezenmeier H; Raghavachar A; Vogt HG; Herrmann F; Freund M; Meusers P; Salama A; Heimpel H
N Engl J Med; 1991 May; 324(19):1297-304. PubMed ID: 2017225
[TBL] [Abstract][Full Text] [Related]
4. [Clinical analysis of predictive factors for the response to antithymocyte globulin in patients with aplastic anemia].
Mori A; Toyoshima N; Saito M; Irie T; Morioka M
Rinsho Ketsueki; 2007 Aug; 48(8):611-7. PubMed ID: 17867296
[TBL] [Abstract][Full Text] [Related]
5. Predictors of response to immunosuppressive therapy with antithymocyte globulin and cyclosporine and prognostic factors for survival in patients with severe aplastic anemia.
Chang MH; Kim KH; Kim HS; Jun HJ; Kim DH; Jang JH; Kim K; Jung CW
Eur J Haematol; 2010 Feb; 84(2):154-9. PubMed ID: 19912311
[TBL] [Abstract][Full Text] [Related]
6. Treatment of severe aplastic anemia with antilymphocyte globulin, cyclosporine and two different granulocyte colony-stimulating factor regimens: a GITMO prospective randomized study.
Locasciulli A; Bruno B; Rambaldi A; Saracco P; Dufour C; Finelli C; Sica S; Varotto S; Arcese W; Locatelli F; Soligo D; Bacigalupo A;
Haematologica; 2004 Sep; 89(9):1054-61. PubMed ID: 15377466
[TBL] [Abstract][Full Text] [Related]
7. Recombinant human interleukin-3 (rH IL-3) in combination with remission induction chemotherapy in patients with relapsed acute myelogenous leukemia (AML): a phase I/II study.
Wielenga JJ; Vellenga E; Groenewegen A; Sonneveld P; Löwenberg B
Leukemia; 1996 Jan; 10(1):43-7. PubMed ID: 8558936
[TBL] [Abstract][Full Text] [Related]
8. Adding growth factors or interleukin-3 to erythropoietin has limited effects on anemia of transfusion-dependent patients with myelodysplastic syndromes unresponsive to erythropoietin alone.
Musto P; Sanpaolo G; D'Arena G; Scalzulli PR; Matera R; Falcone A; Bodenizza C; Perla G; Carotenuto M
Haematologica; 2001 Jan; 86(1):44-51. PubMed ID: 11146570
[TBL] [Abstract][Full Text] [Related]
9. [Interleukin-3 therapy in patients with aplastic anemia refractory to prior therapies].
Miyairi Y; Murai K; Utsugisawa T; Narigasawa Y; Ito S; Shimosegawa K; Sugawara T; Numaoka H; Ono Y; Ito T; Ishida Y; Kuriya S
Rinsho Ketsueki; 1996 Jan; 37(1):22-8. PubMed ID: 8683863
[TBL] [Abstract][Full Text] [Related]
10. Treatment of severe aplastic anemia with antithymocyte globulin.
Rothmann SA; Streeter RR; Bukowski RM; Hewlett JS
Exp Hematol; 1982 Oct; 10(9):809-16. PubMed ID: 6983454
[TBL] [Abstract][Full Text] [Related]
11. [Time course changes in the count of peripheral granulocytes in children with acquired aplastic anemias treated with antithymocyte globulin, cyclosporin A and granulocytic colony stimulating factor].
Bogacheva NIu; Novichkova GA; Litvinov DV; Khachatrian LA; Baĭdil'dina DD; Shneĭder MM; Suntsova EV; Skorobogatova EV; Maschan AA
Ter Arkh; 2002; 74(12):71-7. PubMed ID: 12577848
[TBL] [Abstract][Full Text] [Related]
12. The benefit of ATG in immunosuppressive therapy of children with moderate aplastic anemia.
Jiang S; Wang Y; Shi W; Shao Y; Qiao X; Lin J; Kuang H; Xie X
Pediatr Hematol Oncol; 2009; 26(5):313-20. PubMed ID: 19579077
[TBL] [Abstract][Full Text] [Related]
13. Treatment of severe aplastic anemia with sequential immunosuppression.
Marmont AM; Bacigalupo A; Van Lint MT; Frassoni F; Risso M; Cerri R; Rossi E; Damasio EE; Santini G; Carella M
Exp Hematol; 1983 Oct; 11(9):856-65. PubMed ID: 6357828
[TBL] [Abstract][Full Text] [Related]
14. Immunosuppressive treatment of aplastic anemia in Chinese children with antithymocyte globulin and cyclosporine.
Fang JP; Xu HG; Huang SL; Chen C; Huang K
Pediatr Hematol Oncol; 2006; 23(1):45-50. PubMed ID: 16326412
[TBL] [Abstract][Full Text] [Related]
15. The efficacy of rabbit antithymocyte globulin with cyclosporine in comparison to horse antithymocyte globulin as a first-line treatment in adult patients with severe aplastic anemia: a single-center retrospective study.
Shin SH; Yoon JH; Yahng SA; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Kim HJ; Cho SG; Kim DW; Min WS; Park CW; Lee JW
Ann Hematol; 2013 Jun; 92(6):817-24. PubMed ID: 23318980
[TBL] [Abstract][Full Text] [Related]
16. [Combination of rabbit antithymocyte globulin and cyclosporine A as first-line therapy for adult severe aplastic anemia].
Cao HM; Wang HJ; Zhang L; Jing LP; Zhou K; Yang DL; Li HQ; Liu QG; Yan ZS; Liu YZ; Wu YH; Chu YL; Zhang FK
Zhonghua Xue Ye Xue Za Zhi; 2011 Jan; 32(1):38-42. PubMed ID: 21429400
[TBL] [Abstract][Full Text] [Related]
17. Prospective randomized multicenter study comparing cyclosporin alone versus the combination of antithymocyte globulin and cyclosporin for treatment of patients with nonsevere aplastic anemia: a report from the European Blood and Marrow Transplant (EBMT) Severe Aplastic Anaemia Working Party.
Marsh J; Schrezenmeier H; Marin P; Ilhan O; Ljungman P; McCann S; Socie G; Tichelli A; Passweg J; Hows J; Raghavachar A; Locasciulli A; Bacigalupo A
Blood; 1999 Apr; 93(7):2191-5. PubMed ID: 10090926
[TBL] [Abstract][Full Text] [Related]
18. [Antithymocyte globulin treatment in 11 patients with aplastic anemia].
Hanada M; Kishimoto Y; Nakai K; Shimizu T; Matsumoto N; Miyazaki Y; Yamamoto Y; Amakawa R; Fujimoto M; Fukuhara S
Rinsho Ketsueki; 2000 Jul; 41(7):563-7. PubMed ID: 11020979
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of aplastic anemia with anti-thymocyte globulin and cyclosporine].
Ohnishi S; Nakagawa M; Kobayashi N; Ogasawara M; Kiyama Y; Naohara T; Higa T; Kasai M
Rinsho Ketsueki; 1998 Sep; 39(9):640-4. PubMed ID: 9796396
[TBL] [Abstract][Full Text] [Related]
20. Trilineage recovery by combination therapy with recombinant human granulocyte colony-stimulating factor and erythropoietin in patients with aplastic anemia and refractory anemia.
Bessho M; Jinnai I; Hirashima K; Saito M; Murohashi I; Ino H; Tsuji M; Fukuda M; Maruyama M; Kusumoto S
Stem Cells; 1994 Nov; 12(6):604-15. PubMed ID: 7533579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
